Working groups
Professor Leanne Robinson BSc Adv (Hons) PhD MPHTM is a leading vector-borne diseases researcher. An NHMRC Fellow and Senior Principal Research Fellow, Leanne is Co-Program Director of Health Security and Head of the Vector Borne Diseases and Tropical Public Health Group in the Health Security and Disease Elimination Programs at the Burnet Institute.
Leanne is a recognised expert in malaria epidemiology and implementation research for the control and elimination of malaria and neglected tropical diseases. She leads a highly collaborative and inter-disciplinary research program, with strong links to disease control programs.
Leanne spent 10 years living and working in Papua New Guinea (PNG), leading the implementation of novel cohort studies and intervention trials at the PNG Institute of Medical Research. She is committed to strengthening the capacity of researchers and health workers in endemic countries and has supervised and mentored numerous scientists around the world.
2022 (1)
2021 (1)
The global total number of reported cases is 184 million and the grim milestone of four million deaths has been reached. The cumulative number of cases is equivalent to 23.5 per 1,000 population.
COVID-19 and its impacts on primary health services and public health infectious disease programs in Papua New Guinea. (PUBLIC HEALTH REPORT)PLOS Global Public Health
Yasmin I. Mohamed, Rachael Farquhar, Chris Morgan, Annie Dori, Samuel McEwen, Leanne J. Robinson, Annie Dori, Rachael Farquhar, Yasmin I. Mohamed, Chris Morgan
PLOS Global Public Health
Yasmin I. Mohamed, Rachael Farquhar, Chris Morgan, Annie Dori, Samuel McEwen, Leanne J. Robinson, Annie Dori, Rachael Farquhar, Yasmin I. Mohamed, Chris Morgan
PLOS Global Public Health
Yasmin I. Mohamed, Rachael Farquhar, Chris Morgan, Annie Dori, Samuel McEwen, Leanne J. Robinson, Annie Dori, Rachael Farquhar, Yasmin I. Mohamed, Chris Morgan
We work to increase access to new diagnostic tools for malaria, reduce health inequities and accelerate malaria elimination.
This project will identify the most efficacious gametocyte antigens to prioritise for TBV development, determine which gametocyte antigens induce a natural immune response.
This project compares the performance of novel high sensitivity Plasmodium falciparum rapid diagnostic tests with conventional tests.
The project aims to to reduce malaria and other vector-borne infectious diseases in the South-Pacific i